Cargando…

Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men

Insulin acts in the brain to limit food intake and improve memory function. We have previously shown that 8 weeks of intranasal insulin delivered in four daily doses of 40 IU decrease body weight and enhance word list recall. In the present study, we investigated the effect on body composition, endo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritze, Yvonne, Kern, Werner, Ebner, Eva-Maria, Jahn, Serena, Benedict, Christian, Hallschmid, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262365/
https://www.ncbi.nlm.nih.gov/pubmed/30524368
http://dx.doi.org/10.3389/fendo.2018.00663
_version_ 1783375089027252224
author Ritze, Yvonne
Kern, Werner
Ebner, Eva-Maria
Jahn, Serena
Benedict, Christian
Hallschmid, Manfred
author_facet Ritze, Yvonne
Kern, Werner
Ebner, Eva-Maria
Jahn, Serena
Benedict, Christian
Hallschmid, Manfred
author_sort Ritze, Yvonne
collection PubMed
description Insulin acts in the brain to limit food intake and improve memory function. We have previously shown that 8 weeks of intranasal insulin delivered in four daily doses of 40 IU decrease body weight and enhance word list recall. In the present study, we investigated the effect on body composition, endocrine parameters, and memory performance of 8 weeks of once-daily administration of 160 IU in healthy men. We assumed that intranasal insulin administered before nocturnal sleep, a period of relative metabolic inactivity that moreover benefits memory formation, would be superior to insulin delivery in the morning and placebo administration. After a 2-week baseline period, healthy male normal-weight subjects (mean age, 27.1 ± 0.9 years) received either placebo, 160 IU intranasal insulin in the morning, or 160 IU in the evening (n = 12 per group) for 8 consecutive weeks. Throughout the experiment, we measured body weight and body composition as well as circulating concentrations of glucose, insulin, adrenocorticotropin, cortisol, growth hormone, insulin-like growth-factor 1, adiponectin, and leptin. Declarative and procedural memory function was repeatedly assessed by means of, respectively, word list recall and word-stem priming. We found that neither morning nor evening insulin compared to placebo administration induced discernible changes in body weight and body composition. Delayed recall of words showed slight improvements by insulin administration in the evening, and serum cortisol concentrations were reduced after 2 weeks of insulin administration in the morning compared to the other groups. Results indicate that catabolic long-term effects of central nervous insulin delivery necessitate repetitive, presumably pre-meal delivery schedules. The observed memory improvements, although generally weaker than previously found effects, suggest that sleep after intranasal insulin administration may support its beneficial cognitive impact.
format Online
Article
Text
id pubmed-6262365
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62623652018-12-06 Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men Ritze, Yvonne Kern, Werner Ebner, Eva-Maria Jahn, Serena Benedict, Christian Hallschmid, Manfred Front Endocrinol (Lausanne) Endocrinology Insulin acts in the brain to limit food intake and improve memory function. We have previously shown that 8 weeks of intranasal insulin delivered in four daily doses of 40 IU decrease body weight and enhance word list recall. In the present study, we investigated the effect on body composition, endocrine parameters, and memory performance of 8 weeks of once-daily administration of 160 IU in healthy men. We assumed that intranasal insulin administered before nocturnal sleep, a period of relative metabolic inactivity that moreover benefits memory formation, would be superior to insulin delivery in the morning and placebo administration. After a 2-week baseline period, healthy male normal-weight subjects (mean age, 27.1 ± 0.9 years) received either placebo, 160 IU intranasal insulin in the morning, or 160 IU in the evening (n = 12 per group) for 8 consecutive weeks. Throughout the experiment, we measured body weight and body composition as well as circulating concentrations of glucose, insulin, adrenocorticotropin, cortisol, growth hormone, insulin-like growth-factor 1, adiponectin, and leptin. Declarative and procedural memory function was repeatedly assessed by means of, respectively, word list recall and word-stem priming. We found that neither morning nor evening insulin compared to placebo administration induced discernible changes in body weight and body composition. Delayed recall of words showed slight improvements by insulin administration in the evening, and serum cortisol concentrations were reduced after 2 weeks of insulin administration in the morning compared to the other groups. Results indicate that catabolic long-term effects of central nervous insulin delivery necessitate repetitive, presumably pre-meal delivery schedules. The observed memory improvements, although generally weaker than previously found effects, suggest that sleep after intranasal insulin administration may support its beneficial cognitive impact. Frontiers Media S.A. 2018-11-13 /pmc/articles/PMC6262365/ /pubmed/30524368 http://dx.doi.org/10.3389/fendo.2018.00663 Text en Copyright © 2018 Ritze, Kern, Ebner, Jahn, Benedict and Hallschmid. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Ritze, Yvonne
Kern, Werner
Ebner, Eva-Maria
Jahn, Serena
Benedict, Christian
Hallschmid, Manfred
Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men
title Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men
title_full Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men
title_fullStr Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men
title_full_unstemmed Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men
title_short Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men
title_sort metabolic and cognitive outcomes of subchronic once-daily intranasal insulin administration in healthy men
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262365/
https://www.ncbi.nlm.nih.gov/pubmed/30524368
http://dx.doi.org/10.3389/fendo.2018.00663
work_keys_str_mv AT ritzeyvonne metabolicandcognitiveoutcomesofsubchroniconcedailyintranasalinsulinadministrationinhealthymen
AT kernwerner metabolicandcognitiveoutcomesofsubchroniconcedailyintranasalinsulinadministrationinhealthymen
AT ebnerevamaria metabolicandcognitiveoutcomesofsubchroniconcedailyintranasalinsulinadministrationinhealthymen
AT jahnserena metabolicandcognitiveoutcomesofsubchroniconcedailyintranasalinsulinadministrationinhealthymen
AT benedictchristian metabolicandcognitiveoutcomesofsubchroniconcedailyintranasalinsulinadministrationinhealthymen
AT hallschmidmanfred metabolicandcognitiveoutcomesofsubchroniconcedailyintranasalinsulinadministrationinhealthymen